Delivery Order V797D50492-36C25923F0174

The U.S. Department of Defense's Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 1,801-2,400 unit vials of the pharmaceutical product ADVATE. The contract has a completion date of February 15, 2024 and a potential value of $31,117.60. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, which has a total...

This is a delivery order contract awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to Takeda Pharmaceuticals America Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract is for the delivery of ADVATE Antihemophilic Factor, Recombinant, 2000 unit/vial injection, with a ceiling value of $10,783.80 and a completion date of January 17, 2025. The contract is placed under the General Services Administration (GSA) Pharmaceuticals and...

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $31,117.60 and is for the delivery of Advate, a brand name blood clotting factor VIII drug, in 1,801-2,400 unit vials. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 26, 2024. DMS Pharmaceutical Group holds a larger...

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $56,570.40 firm fixed-price delivery order is for the supply of 3,601-4,800 unit vials of the medication ADVATE. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC enables the...

The Defense Logistics Agency awarded a delivery order valued at $28,038.47 to Amerisourcebergen Drug Corporation for 4561453862 units of CATHFLO ACTIVASE 2 MG VIALS. The contract has a firm fixed price and period of performance from July 10, 2023 through July 11, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense...

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,808,989 units of ACTIVASE 50 MG VIALS. The contract has a completion date of March 1, 2024 and a potential value of $2,864.71. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. This delivery order contract is part of a...

The Defense Logistics Agency awarded a $7,638 delivery order to Amerisourcebergen Drug Corporation for 4561739570 ACTIVASE 50 MG VIALS. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products from its Conshohocken, Pennsylvania facility by August 9, 2023 to support DLA programs. No subcontractors or set aside designations were indicated. DLA manages the global supply chain for the Department of Defense, ensuring medical supplies and equipment are available...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a ceiling value of $4,079.39 and a completion date of May 14, 2025. The contract is a firm fixed-price delivery order, which is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor,...

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as AmerisourceBergen). The contract is for the supply of ACTIVASE 100 MG VIALS, a specialty pharmaceutical product, with a ceiling value of $47,227.00 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a specialty pharmaceutical product, with a potential value of $6,650.10. The contract does not have a set-aside designation and the period of performance is from the award date of February 5, 2024 through February 6, 2024....